Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1027643
rs1027643
LOC105379082
T 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs1027643
rs1027643
LOC105379082
T 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2283873
rs2283873
TCN2
A 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2283873
rs2283873
TCN2
A 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2495478
rs2495478
PCSK9
T 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2495478
rs2495478
PCSK9
T 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs3755132
rs3755132 		G 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs3755132
rs3755132 		G 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs5955543
rs5955543
NHS
G 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs5955543
rs5955543
NHS
G 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs790356
rs790356
DLG2
G 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs790356
rs790356
DLG2
G 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs807624
rs807624 		A 0.800 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs807624
rs807624 		A 0.800 GeneticVariation GWASCAT A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs1423753702
rs1423753702
WT1
0.710 GeneticVariation BEFREE We report on a novel WT1 nonsense mutation (c.1105C>T), introducing a premature stop codon in exon 8 (p.Q369X), in a young XY male patient who presented with bilateral cryptorchidism, nystagmus, mild proteinuria and WT, but no sign of severe nephropathy. 19048299

2009
dbSNP: rs10060683
rs10060683 		0.700 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs11913239
rs11913239
TCN2
0.700 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs1243010179
rs1243010179
CTCF
0.700 GeneticVariation UNIPROT

dbSNP: rs1553551874
rs1553551874
DIS3L2
A 0.700 GeneticVariation CLINVAR

dbSNP: rs16988855
rs16988855
TCN2
0.700 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2009857
rs2009857
TCN2
0.700 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2221269
rs2221269
LOC105379082
0.700 GeneticVariation GWASDB A genome-wide association study identifies susceptibility loci for Wilms tumor. 22544364

2012
dbSNP: rs2234584
rs2234584
WT1
0.700 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249

2013
dbSNP: rs2234584
rs2234584
WT1
0.700 GeneticVariation UNIPROT ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. 25356965

2015
dbSNP: rs2234584
rs2234584
WT1
0.700 GeneticVariation UNIPROT Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. 27854360

2017